600535.SH
Tasly Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 13.65
−0.36%Forward multiples
Based on analyst estimates
- P/E forward
- 9.03x
- P/E 2026E
- 15.87x
- P/E 2027E
- 13.61x
- P/E 2028E
- 11.81x
- P/S forward
- 2.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.46x
- PEG TTM
- 0.18x
- Price / book
- 1.58x
- Price / sales
- 2.47x
- Price / cash flow
- 9.17x
Enterprise value
- Enterprise value
- CNY 21.2B
- EV / sales
- 2.54x
- EV / EBITDA
- 11.67x
- EV / EBIT
- 15.12x
- Market cap
- CNY 20.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026